78% of your workforce is already using AI tools you never approved. The governance conversation cannot wait.
Most regulated L&D teams are not stuck because AI is too risky. They are stuck because no one has written down which rules actually apply. In a 2026 LTEN webinar poll, 48% of life sciences L&D professionals named compliance risk as their biggest blocker to scaling AI. Only 9% say regulation truly prevents AI use. The gap between perceived and actual risk is costing organisations time they do not have.
Watch the on-demand session to see exactly how one global pharma organisation went from 300 cautious pilot users to 100,000+ across 10+ languages, inside a fully regulated environment.
- Why most AI pilots stall and the three structural reasons they never scale
- A practical three-lane governance model your legal team designs once, freeing routine L&D work from constant review queues
- The four compliance checkpoints every AI-assisted training asset passed in a GxP environment
- A self-assessment to score where your organisation honestly stands on readiness to scale
- How 100,315 users were trained and enabled with a 98% value rating and zero compliance compromises
The regulations never changed. The organisations that scaled AI simply stopped assuming which ones applied.
Speaker:
